RE: Presentation18 Oct 2018 20:37
Just to touch on some of the points raised:
They were showing growth across all regions last year and YTD. No specific mention was made of India but they did make reference to reduced profit margins on the APAC business, which I would have thought is a reference to them.
The CEO, via video, hinted that they are looking at doing more diversification and that the recent This deal should be the first of many.
They said that the breakeven statement referred to the NIPT testing business, rather than the company as a whole.